Schonfeld Strategic Advisors LLC Karuna Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$161.01 - $317.85 $185,322 - $365,845	-1,151 Reduced 5.78%	18,762 $5.94 Million
Q3 2023 Nov 14, 2023	BUY	$164.66 - $218.08 $447,381 - $592,523	2,717 Added 15.8%	19,913 $3.37 Million
Q2 2023 Aug 14, 2023	SELL	$176.32 - $240.22 $2.48 Million - $3.37 Million	-14,044 Reduced 44.96%	17,196 $3.73 Million
Q1 2023 May 15, 2023	BUY	$161.33 - $204.36 $2.91 Million - $3.69 Million	18,040 Added 136.67%	31,240 $5.67 Million
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $361,225 - $446,642	1,886 Added 16.67%	13,200 $2.59 Million
Q3 2022 Nov 14, 2022	SELL	$123.79 - $277.42 $369,636 - $828,376	-2,986 Reduced 20.88%	11,314 $2.55 Million
Q2 2022 Aug 15, 2022	BUY	$93.97 - $143.33 $366,483 - $558,987	3,900 Added 37.5%	14,300 $1.81 Million
Q1 2022 May 16, 2022	BUY	$98.9 - $132.37 $1.03 Million - $1.38 Million	10,400 New	10,400 $1.32 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.